Ursane hybrids with 5-amino-1,2,3,4-thiatriazole, 1-tetrazole-5-thione, and 1-tetrazole-5-amines and study of their inhibition of main SARS-CoV-2 protease
•New ursane hybrids with tetrazole and 5-aminothiatriazoles were synthesized.•New compounds were tested in vitro for SARS-CoV-2 3CLpro inhibition.•Hybrids with 1-tetrazol-5-thione inhibited 3CLpro and were non-toxic for Vero cells.•Molecular docking assumed a disulfide bonding between tetrazole-thio...
Saved in:
Published in | Steroids Vol. 220; p. 109638 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.08.2025
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | •New ursane hybrids with tetrazole and 5-aminothiatriazoles were synthesized.•New compounds were tested in vitro for SARS-CoV-2 3CLpro inhibition.•Hybrids with 1-tetrazol-5-thione inhibited 3CLpro and were non-toxic for Vero cells.•Molecular docking assumed a disulfide bonding between tetrazole-thiol and cysteine of 3CLpro.•The external bonding of triterpenoid is essential for the affinity with the enzyme.
A series of new heterocyclic ursane and 28-norursane hybrids − derivatives of 5-amino-1,2,3,4-thiatriazole, 1-tetrazole–5-thione, and 1-tetrazole–5-amines were prepared. Reacting triterpenoids holding NCS groups at different distances from the pentacyclic backbone with hydrazine hydrate resulted in ursane-derived hydrazinecarbothioamides. Subsequent nitrosation afforded terpenoid derivatives of 5-amino-1,2,3,4-thiatriazole. Heterocyclization of amino-thioureas with 3β-acetoxyurs-12-en-28-yl substituent under the action of Hg(OAc)2-NaN3 led to hybrids of 1-tetrazole–5-amines. 1-Tetrazole–5-thiones with different positions of heterocycle relative to the triterpene skeleton were prepared by coupling sodium azide with triterpene isothiocyanates. The activity of the new heterocyclic derivatives as inhibitors of 3CLpro of SARS-CoV-2 was investigated. Remarkable inhibition was observed for the 1-tetrazole-5-thione hybrids of triterpenoids. The highest activity among the studied compounds was provided by the combination of a 1-tetrazole-5-thione moiety at the C(28)H2 group of the ursane frame having a free OH group at the 3-position. Molecular docking assumed the covalent binding of 3CLpro via the formation of a disulfide bond between the thiol groups of the catalytic Cys145 and the tetrazole heterocycle of the new hybrid compounds. The triterpenoid backbone provided multiple external hydrophobic contacts essential for the stability of the complex. The results demonstrate the potential of heterocyclic thione hybrids as non-peptidomimetic covalent inhibitors targeting 3CLpro protease (3-Chymotrypsin-like Protease). |
---|---|
AbstractList | •New ursane hybrids with tetrazole and 5-aminothiatriazoles were synthesized.•New compounds were tested in vitro for SARS-CoV-2 3CLpro inhibition.•Hybrids with 1-tetrazol-5-thione inhibited 3CLpro and were non-toxic for Vero cells.•Molecular docking assumed a disulfide bonding between tetrazole-thiol and cysteine of 3CLpro.•The external bonding of triterpenoid is essential for the affinity with the enzyme.
A series of new heterocyclic ursane and 28-norursane hybrids − derivatives of 5-amino-1,2,3,4-thiatriazole, 1-tetrazole–5-thione, and 1-tetrazole–5-amines were prepared. Reacting triterpenoids holding NCS groups at different distances from the pentacyclic backbone with hydrazine hydrate resulted in ursane-derived hydrazinecarbothioamides. Subsequent nitrosation afforded terpenoid derivatives of 5-amino-1,2,3,4-thiatriazole. Heterocyclization of amino-thioureas with 3β-acetoxyurs-12-en-28-yl substituent under the action of Hg(OAc)2-NaN3 led to hybrids of 1-tetrazole–5-amines. 1-Tetrazole–5-thiones with different positions of heterocycle relative to the triterpene skeleton were prepared by coupling sodium azide with triterpene isothiocyanates. The activity of the new heterocyclic derivatives as inhibitors of 3CLpro of SARS-CoV-2 was investigated. Remarkable inhibition was observed for the 1-tetrazole-5-thione hybrids of triterpenoids. The highest activity among the studied compounds was provided by the combination of a 1-tetrazole-5-thione moiety at the C(28)H2 group of the ursane frame having a free OH group at the 3-position. Molecular docking assumed the covalent binding of 3CLpro via the formation of a disulfide bond between the thiol groups of the catalytic Cys145 and the tetrazole heterocycle of the new hybrid compounds. The triterpenoid backbone provided multiple external hydrophobic contacts essential for the stability of the complex. The results demonstrate the potential of heterocyclic thione hybrids as non-peptidomimetic covalent inhibitors targeting 3CLpro protease (3-Chymotrypsin-like Protease). A series of new heterocyclic ursane and 28-norursane hybrids - derivatives of 5-amino-1,2,3,4-thiatriazole, 1-tetrazole-5-thione, and 1-tetrazole-5-amines were prepared. Reacting triterpenoids holding NCS groups at different distances from the pentacyclic backbone with hydrazine hydrate resulted in ursane-derived hydrazinecarbothioamides. Subsequent nitrosation afforded terpenoid derivatives of 5-amino-1,2,3,4-thiatriazole. Heterocyclization of amino-thioureas with 3β-acetoxyurs-12-en-28-yl substituent under the action of Hg(OAc)2-NaN3 led to hybrids of 1-tetrazole-5-amines. 1-Tetrazole-5-thiones with different positions of heterocycle relative to the triterpene skeleton were prepared by coupling sodium azide with triterpene isothiocyanates. The activity of the new heterocyclic derivatives as inhibitors of 3CLpro of SARS-CoV-2 was investigated. Remarkable inhibition was observed for the 1-tetrazole-5-thione hybrids of triterpenoids. The highest activity among the studied compounds was provided by the combination of a 1-tetrazole-5-thione moiety at the C(28)H2 group of the ursane frame having a free OH group at the 3-position. Molecular docking assumed the covalent binding of 3CLpro via the formation of a disulfide bond between the thiol groups of the catalytic Cys145 and the tetrazole heterocycle of the new hybrid compounds. The triterpenoid backbone provided multiple external hydrophobic contacts essential for the stability of the complex. The results demonstrate the potential of heterocyclic thione hybrids as non-peptidomimetic covalent inhibitors targeting 3CLpro protease (3-Chymotrypsin-like Protease).A series of new heterocyclic ursane and 28-norursane hybrids - derivatives of 5-amino-1,2,3,4-thiatriazole, 1-tetrazole-5-thione, and 1-tetrazole-5-amines were prepared. Reacting triterpenoids holding NCS groups at different distances from the pentacyclic backbone with hydrazine hydrate resulted in ursane-derived hydrazinecarbothioamides. Subsequent nitrosation afforded terpenoid derivatives of 5-amino-1,2,3,4-thiatriazole. Heterocyclization of amino-thioureas with 3β-acetoxyurs-12-en-28-yl substituent under the action of Hg(OAc)2-NaN3 led to hybrids of 1-tetrazole-5-amines. 1-Tetrazole-5-thiones with different positions of heterocycle relative to the triterpene skeleton were prepared by coupling sodium azide with triterpene isothiocyanates. The activity of the new heterocyclic derivatives as inhibitors of 3CLpro of SARS-CoV-2 was investigated. Remarkable inhibition was observed for the 1-tetrazole-5-thione hybrids of triterpenoids. The highest activity among the studied compounds was provided by the combination of a 1-tetrazole-5-thione moiety at the C(28)H2 group of the ursane frame having a free OH group at the 3-position. Molecular docking assumed the covalent binding of 3CLpro via the formation of a disulfide bond between the thiol groups of the catalytic Cys145 and the tetrazole heterocycle of the new hybrid compounds. The triterpenoid backbone provided multiple external hydrophobic contacts essential for the stability of the complex. The results demonstrate the potential of heterocyclic thione hybrids as non-peptidomimetic covalent inhibitors targeting 3CLpro protease (3-Chymotrypsin-like Protease). A series of new heterocyclic ursane and 28-norursane hybrids - derivatives of 5-amino-1,2,3,4-thiatriazole, 1-tetrazole-5-thione, and 1-tetrazole-5-amines were prepared. Reacting triterpenoids holding NCS groups at different distances from the pentacyclic backbone with hydrazine hydrate resulted in ursane-derived hydrazinecarbothioamides. Subsequent nitrosation afforded terpenoid derivatives of 5-amino-1,2,3,4-thiatriazole. Heterocyclization of amino-thioureas with 3β-acetoxyurs-12-en-28-yl substituent under the action of Hg(OAc) -NaN led to hybrids of 1-tetrazole-5-amines. 1-Tetrazole-5-thiones with different positions of heterocycle relative to the triterpene skeleton were prepared by coupling sodium azide with triterpene isothiocyanates. The activity of the new heterocyclic derivatives as inhibitors of 3CLpro of SARS-CoV-2 was investigated. Remarkable inhibition was observed for the 1-tetrazole-5-thione hybrids of triterpenoids. The highest activity among the studied compounds was provided by the combination of a 1-tetrazole-5-thione moiety at the C(28)H group of the ursane frame having a free OH group at the 3-position. Molecular docking assumed the covalent binding of 3CLpro via the formation of a disulfide bond between the thiol groups of the catalytic Cys145 and the tetrazole heterocycle of the new hybrid compounds. The triterpenoid backbone provided multiple external hydrophobic contacts essential for the stability of the complex. The results demonstrate the potential of heterocyclic thione hybrids as non-peptidomimetic covalent inhibitors targeting 3CLpro protease (3-Chymotrypsin-like Protease). |
ArticleNumber | 109638 |
Author | Popov, Sergey A. Pokrovsky, Mikhail.A. Belenkaya, Svetlana V. Chirkova, Varvara Yu Shults, Elvira E. Volosnikova, Ekaterina A. Baev, Dmitry S. Shcherbakov, Dmitry N. Pokrovsky, Andrey G. Hamad, Mohammad S. |
Author_xml | – sequence: 1 givenname: Sergey A. surname: Popov fullname: Popov, Sergey A. email: spopov@nioch.nsc.ru organization: Novosibirsk Institute of Organic Chemistry, Acad. Lavrentyev ave. 9, Novosibirsk 630090, Russia – sequence: 2 givenname: Elvira E. surname: Shults fullname: Shults, Elvira E. organization: Novosibirsk Institute of Organic Chemistry, Acad. Lavrentyev ave. 9, Novosibirsk 630090, Russia – sequence: 3 givenname: Dmitry S. surname: Baev fullname: Baev, Dmitry S. organization: Novosibirsk Institute of Organic Chemistry, Acad. Lavrentyev ave. 9, Novosibirsk 630090, Russia – sequence: 4 givenname: Varvara Yu surname: Chirkova fullname: Chirkova, Varvara Yu organization: Institute of Biology and Biotechnology, Altay State University, 656049 Barnaul, Russia – sequence: 5 givenname: Ekaterina A. surname: Volosnikova fullname: Volosnikova, Ekaterina A. organization: State Research Center of Virology and Biotechnology VECTOR, Rospotrebnadzor, 630559 Koltsovo, Russia – sequence: 6 givenname: Svetlana V. surname: Belenkaya fullname: Belenkaya, Svetlana V. organization: State Research Center of Virology and Biotechnology VECTOR, Rospotrebnadzor, 630559 Koltsovo, Russia – sequence: 7 givenname: Dmitry N. surname: Shcherbakov fullname: Shcherbakov, Dmitry N. organization: Institute of Biology and Biotechnology, Altay State University, 656049 Barnaul, Russia – sequence: 8 givenname: Mikhail.A. surname: Pokrovsky fullname: Pokrovsky, Mikhail.A. organization: Novosibirsk State University, Pirogova St. 1, Novosibirsk 630090, Russia – sequence: 9 givenname: Mohammad S. surname: Hamad fullname: Hamad, Mohammad S. organization: Novosibirsk State University, Pirogova St. 1, Novosibirsk 630090, Russia – sequence: 10 givenname: Andrey G. surname: Pokrovsky fullname: Pokrovsky, Andrey G. organization: Novosibirsk State University, Pirogova St. 1, Novosibirsk 630090, Russia |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40409429$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUU1vFCEYJqbGbqt_oeHoYVhhgBm42Wy0mjQxsdZ4IwzzTobNzlCBrVl_Sn-tTLf14MUT4X0-XnieM3QyhxkQumB0zShr3m3XKUMMvk_rmtayDHXD1Qu0YqpVRKqmPUErSrkmrFY_TtFZSltKacN1_QqdCiqoFrVeoYfbmOwMeDx0sZjhXz6PWBI7-TkQVtUVrwTJo7c5evs77KDCjGTI8fFC5IKVl1XYzv0_yOIB6RFIed8fcBhwHsFH7OfRdz4X4TKbrJ_xzeXXG7IJ30mN72LIYBO8Ri8Hu0vw5uk8R7cfP3zbfCLXX64-by6vieOszaSXVg0dtBo448IpC84qJWpQquNNL2lXCB0dhFSubYBppXsphRYtaEFbx8_R26NvWfxzDymbyScHu13JJeyT4TVtS8YtlYV68UTddxP05i76ycaDec6zEJojwcWQUoThL4VRsxRntua5OLMUZ47FFeH7oxDKT-89RJOch9lB7yO4bPrg_2fxB94Qo30 |
Cites_doi | 10.1039/b810300c 10.1021/acs.jctc.1c00302 10.1016/S0065-2725(08)60854-5 10.3390/ijms222111739 10.1016/j.molstruc.2021.131751 10.1016/j.steroids.2019.108524 10.1093/nar/28.1.235 10.1371/journal.pone.0042846 10.1126/science.abl4784 10.1016/j.bioorg.2021.104889 10.1016/j.bmcl.2012.06.080 10.1016/j.ejmech.2024.116788 10.1080/17415993.2023.2193669 10.1007/s00044-016-1680-1 10.1023/A:1015387108748 10.3390/v13040609 10.1016/j.ejmech.2019.05.071 10.3390/ph15060744 10.1021/acsptsci.0c00130 10.2174/138955709788681618 10.2174/18755348MTEyoMzEFz 10.1135/cccc2009015 10.1007/s10593-021-03001-6 10.1134/S1070428017110185 10.2174/0929867324666171009122612 10.1016/j.ijantimicag.2019.07.015 10.1021/jo01355a601 10.1016/j.crci.2012.12.018 10.1139/v57-116 10.1021/acs.jmedchem.2c01005 10.3390/life12111706 10.1134/S1070363217040119 10.1016/j.ejmech.2023.115491 10.1021/jo00027a038 10.1016/j.bmc.2018.07.025 10.1021/ol006465b 10.1016/S0968-0896(02)00239-0 10.1002/slct.202200706 10.1016/j.bmc.2015.12.048 10.1016/j.antiviral.2013.02.003 10.5012/bkcs.2012.33.1.55 10.1016/j.bmcl.2019.04.028 10.1070/RCR4864 10.1016/j.exppara.2020.107935 10.1007/s10593-024-03350-y 10.1038/s41422-022-00640-y 10.1007/s00894-022-05341-2 10.1139/v59-015 10.1039/C2MD20327H 10.2174/1568026620666201207095117 10.1039/C5NP00015G 10.1016/S0040-4020(01)86975-1 10.1016/j.biopha.2017.07.152 10.1038/srep27403 10.1021/ci500118s 10.1016/j.molstruc.2015.07.017 10.3390/molecules25204604 |
ContentType | Journal Article |
Copyright | 2025 Elsevier Inc. Copyright © 2025 Elsevier Inc. All rights reserved. Copyright © 2025. Published by Elsevier Inc. |
Copyright_xml | – notice: 2025 Elsevier Inc. – notice: Copyright © 2025 Elsevier Inc. All rights reserved. – notice: Copyright © 2025. Published by Elsevier Inc. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.steroids.2025.109638 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry |
EISSN | 1878-5867 |
ExternalDocumentID | 40409429 10_1016_j_steroids_2025_109638 S0039128X25000790 |
Genre | Journal Article |
GroupedDBID | --- --K --M -~X .55 .GJ .~1 0R~ 123 1B1 1RT 1~. 1~5 29Q 3O- 4.4 457 4G. 53G 5RE 5VS 7-5 71M 8P~ 9JM AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXUO AAYWO ABFNM ABGSF ABJNI ABMAC ABUDA ABWVN ABXDB ACDAQ ACGFS ACIUM ACKIV ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADUVX AEBSH AEHWI AEIPS AEKER AENEX AEUPX AFJKZ AFPUW AFTJW AFXIZ AGCQF AGHFR AGQPQ AGRDE AGRNS AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV C45 CS3 EBS EFJIC EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HLW HVGLF HZ~ IHE J1W J5H KOM LX3 M41 MO0 N9A O-L O9- OAUVE OVD OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SBG SCC SDF SDG SDP SES SEW SPCBC SSH SSU SSZ T5K TEORI WH7 WUQ X7M ZGI ~G- AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c317t-d5a8fbe79e3134c8aeca8842e88b36d50b5a8b0f458c76e1989d554947e9407c3 |
IEDL.DBID | .~1 |
ISSN | 0039-128X 1878-5867 |
IngestDate | Wed Jul 02 02:56:52 EDT 2025 Sat Jun 14 01:31:05 EDT 2025 Thu Jul 03 08:38:15 EDT 2025 Sat Jul 05 17:11:23 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Ursane hybrid Covalent bonding SARS-CoV-2 protease Thione Tetrazole Molecular docking |
Language | English |
License | Copyright © 2025 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c317t-d5a8fbe79e3134c8aeca8842e88b36d50b5a8b0f458c76e1989d554947e9407c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 40409429 |
PQID | 3207202705 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_3207202705 pubmed_primary_40409429 crossref_primary_10_1016_j_steroids_2025_109638 elsevier_sciencedirect_doi_10_1016_j_steroids_2025_109638 |
PublicationCentury | 2000 |
PublicationDate | 2025-08-01 |
PublicationDateYYYYMMDD | 2025-08-01 |
PublicationDate_xml | – month: 08 year: 2025 text: 2025-08-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Steroids |
PublicationTitleAlternate | Steroids |
PublicationYear | 2025 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Holm (b0265) 1976; 20 van de Sand, Bormann, Alt, Schipper, Heilingloh, Steinmann, Todt, Dittmer, Elsner, Witzke, Krawczyk (b0045) 2021; 13 Popov, Qi, Wang, Shults (b0180) 2023 La Monica, Bono, Lauria, Martorana (b0285) 2022; 65 Popova, Trifonov, Ostrovskii (b0060) 2019; 88 Popov, Semenova, Baev, Frolova, Shults, Wang, Turks (b0270) 2020; 153 Leyva-ramos, Cardoso-ortiz (b0055) 2021 Sabbah, Hajjo, Bardaweel, Zhong (b0010) 2021; 21 Alam, Nami, Husain, Lee, Park (b0115) 2013; 16 Vishwakarma, Gadipelly, Mannepalli (b0070) 2022; 7 Sudhakar, Rajaram, Ramaiah, Rao, Ramraj (b0145) 1987; 64 Zhu, Borrelli, Greenwood, Day, Abel, Farid, Harder (b0215) 2014; 54 Pokorny, Borkova, Urban (b0125) 2018; 25 Kuczynska, Bończak, Rárová, Kvasnicová, Strnad, Pakulski, Cmoch, Fiałkowski (b0135) 2022; 1250 Schrodinger small molecule drug discovery suite, Schrödinger, (2022) LLC, New York. Sacco, Hu, Gongora, Meilleur, Kemp, Zhang, Wang, Chen (b0210) 2022; 32 Zhang, Jin, Liu, Jin, Jin, Wei (b0155) 2020; 216 Suenaga, Okimoto, Hirano, Fukui (b0220) 2012; 7 Zhang, Wang, Ba, Xu (b0165) 2019; 178 Petrova, Poptsov, Thu, Van Tuyen, Khusnutdinova, Babkov, Kazakova (b0130) 2021; 57 Ma, Hu, Townsend, Lagarias, Marty, Kolocouris, Wang (b0310) 2020; 3 Silva, Freitas, Campos, Kimani, Silva, Borges, Pita, Santos (b0020) 2021; 22 Tohmé, Giménez, Peralta, Colombo, Delgui (b0035) 2019; 54 Shcherbakov, Baev, Kalinin, Dalinger, Chirkova, Belenkaya, Khvostov, Krut’Ko, Medved’Ko, Volosnikova, Sharlaeva, Shanshin, Tolstikova, Yarovaya, Maksyutov, Salakhutdinov, Vatsadze (b0190) 2021 Myznikov, Vorona, Artamonova, Zevatskii (b0255) 2017; 87 Kvasnica, Urban, Dickinson, Sarek (b0120) 2015; 32 Alam, Alam, Nami, Khan, Ahmad, Lee (b0100) 2015; 1099 Popov, Shults, Shpatov, Semenova (b0275) 2024; 60 Pang, Xu, Liu, Li, Chen (b0280) 2023; 257 Zhang, Zhang, Li, Wei, Jin, Piao (b0150) 2019; 29 Meewan, Kattoula, Kattoula, Skinner, Fajtová, Giardini, Woodworth, McKerrow, Lage de Siqueira-Neto, O’donoghue, Abagyan (b0300) 2022; 15 Timilsina, Ghimire, Timalsina, Nitz, Wild, Freed, Gaur (b0050) 2016; 6 Batey, Powell (b0260) 2000; 2 Sun, Chen, Su, Li, Jiang, Gao, Chigan, Ding, Zhai, Yang (b0295) 2021; 112 Herr (b0065) 2002; 10 Zhan, Li, Liu, De Clercq (b0090) 2009; 9 Lu, Wu, Ghoreishi, Chen, Wang, Damm, Ross, Dahlgren, Russell, Von Bargen, Abel, Friesner, Harder (b0200) 2021; 17 Nogara, Omage, Bolzan, Delgado, Orian, Rocha (b0305) 2022; 28 Aggarwal, Mahapatra, Kumar, Bhardwaj, Hartmann, Haupenthal, Kumar (b0110) 2016; 24 Singh, Gautam, Chandel, Ghosh, Dey, Roy, Ravichandiran, Ghosh (b0025) 2020; 25 Bielenica, Szulczyk, Olejarz, Madeddu, Giliberti, Materek, Koziol, Struga (b0080) 2017; 94 Popova, Protas, Trifonov (b0095) 2017; 17 Hrabálek, Pus, Baranek, Kunes, Palat (b0240) 2002; 38 Han, Lee, Kim, Kim, Lee, Gyoung (b0250) 2012; 33 Zhu, Zhang, Lin, Lyu, Lu, Chen, Zhang, Zhang, Chen (b0005) 2023 Zabrocki, Dunbar, Marshall, Toth, Marshall (b0075) 1992; 57 Ren, Anaya-Eugenio, Czarnecki, Ninh, Yuan, Chai, Soejarto, Burdette, de Blanco, Kinghorn (b0175) 2018; 26 Owen, Allerton, Anderson, Aschenbrenner, Avery, Berritt, Boras, Cardin, Carlo, Coffman, Dantonio, Di, Eng, Ferre, Gajiwala, Gibson, Greasley, Hurst, Kadar, Kalgutkar, Lee, Lee, Liu, Mason, Noell, Novak, Obach, Ogilvie, Patel, Pettersson, Rai, Reese, Sammons, Sathish, Singh, Steppan, Stewart, Tuttle, Updyke, Verhoest, Wei, Yang, Zhu (b0290) 2021; 374 Lieber, Ramachandran (b0245) 1959; 37 Kong, Li, Liao, Zhang, Sun, Zhu, Zhang, Wang, Wu, Fang, Zhu (b0040) 2013; 98 Zorina, Kaledina, Motsepuro, Anokhina, Marchenko, Selivanov, Zarubaev, Trifonov (b0085) 2017; 53 Berman (b0205) 2000; 28 Tkachev, Denisov (b0170) 1994; 50 Lieber, Oftedahl, Pillai, Hites (b0225) 1957; 22 Katritzky, Meher, Narindoshvili (b0235) 2009; 74 He, Liang, Shen, Zhang, Liu, Yang, Liu, Wang, Xie, Hu, Song, Wang (b0030) 2022; 12 Jourdan, Bubert, Leese, Smith, Ferrandis, Regis-Lydi, Newman, Purohit, Reed, Potter (b0160) 2008; 6 Liu, Yang, Jin, Hu, Xue, Yang (b0185) 2016; 25 Dang, Qian, Ho, Zhu, Lee, Huang, Chen (b0140) 2012; 22 Penov-Gaši, Oklješa, Petri, Ćelić, Djurendić, Klisurić, Csanadi, Batta, Nikolić, Jakimov, Sakač (b0105) 2013; 4 Liu (b0015) 2024; 278 Lieber, Pillai, Hites (b0230) 1957; 35 Holm (10.1016/j.steroids.2025.109638_b0265) 1976; 20 Pokorny (10.1016/j.steroids.2025.109638_b0125) 2018; 25 Aggarwal (10.1016/j.steroids.2025.109638_b0110) 2016; 24 Dang (10.1016/j.steroids.2025.109638_b0140) 2012; 22 Popov (10.1016/j.steroids.2025.109638_b0180) 2023 Sacco (10.1016/j.steroids.2025.109638_b0210) 2022; 32 10.1016/j.steroids.2025.109638_b0195 Meewan (10.1016/j.steroids.2025.109638_b0300) 2022; 15 Tohmé (10.1016/j.steroids.2025.109638_b0035) 2019; 54 Alam (10.1016/j.steroids.2025.109638_b0115) 2013; 16 Kong (10.1016/j.steroids.2025.109638_b0040) 2013; 98 He (10.1016/j.steroids.2025.109638_b0030) 2022; 12 Zhu (10.1016/j.steroids.2025.109638_b0005) 2023 Singh (10.1016/j.steroids.2025.109638_b0025) 2020; 25 Owen (10.1016/j.steroids.2025.109638_b0290) 2021; 374 Sun (10.1016/j.steroids.2025.109638_b0295) 2021; 112 Nogara (10.1016/j.steroids.2025.109638_b0305) 2022; 28 Lieber (10.1016/j.steroids.2025.109638_b0230) 1957; 35 Han (10.1016/j.steroids.2025.109638_b0250) 2012; 33 Petrova (10.1016/j.steroids.2025.109638_b0130) 2021; 57 Lieber (10.1016/j.steroids.2025.109638_b0225) 1957; 22 Herr (10.1016/j.steroids.2025.109638_b0065) 2002; 10 Katritzky (10.1016/j.steroids.2025.109638_b0235) 2009; 74 Zhang (10.1016/j.steroids.2025.109638_b0165) 2019; 178 Zhu (10.1016/j.steroids.2025.109638_b0215) 2014; 54 Suenaga (10.1016/j.steroids.2025.109638_b0220) 2012; 7 Popov (10.1016/j.steroids.2025.109638_b0270) 2020; 153 Popova (10.1016/j.steroids.2025.109638_b0095) 2017; 17 Shcherbakov (10.1016/j.steroids.2025.109638_b0190) 2021 Popov (10.1016/j.steroids.2025.109638_b0275) 2024; 60 Kuczynska (10.1016/j.steroids.2025.109638_b0135) 2022; 1250 van de Sand (10.1016/j.steroids.2025.109638_b0045) 2021; 13 Popova (10.1016/j.steroids.2025.109638_b0060) 2019; 88 Lieber (10.1016/j.steroids.2025.109638_b0245) 1959; 37 Zorina (10.1016/j.steroids.2025.109638_b0085) 2017; 53 La Monica (10.1016/j.steroids.2025.109638_b0285) 2022; 65 Jourdan (10.1016/j.steroids.2025.109638_b0160) 2008; 6 Liu (10.1016/j.steroids.2025.109638_b0015) 2024; 278 Kvasnica (10.1016/j.steroids.2025.109638_b0120) 2015; 32 Sudhakar (10.1016/j.steroids.2025.109638_b0145) 1987; 64 Myznikov (10.1016/j.steroids.2025.109638_b0255) 2017; 87 Batey (10.1016/j.steroids.2025.109638_b0260) 2000; 2 Vishwakarma (10.1016/j.steroids.2025.109638_b0070) 2022; 7 Zabrocki (10.1016/j.steroids.2025.109638_b0075) 1992; 57 Liu (10.1016/j.steroids.2025.109638_b0185) 2016; 25 Berman (10.1016/j.steroids.2025.109638_b0205) 2000; 28 Sabbah (10.1016/j.steroids.2025.109638_b0010) 2021; 21 Tkachev (10.1016/j.steroids.2025.109638_b0170) 1994; 50 Leyva-ramos (10.1016/j.steroids.2025.109638_b0055) 2021 Alam (10.1016/j.steroids.2025.109638_b0100) 2015; 1099 Zhan (10.1016/j.steroids.2025.109638_b0090) 2009; 9 Lu (10.1016/j.steroids.2025.109638_b0200) 2021; 17 Penov-Gaši (10.1016/j.steroids.2025.109638_b0105) 2013; 4 Zhang (10.1016/j.steroids.2025.109638_b0155) 2020; 216 Ma (10.1016/j.steroids.2025.109638_b0310) 2020; 3 Silva (10.1016/j.steroids.2025.109638_b0020) 2021; 22 Zhang (10.1016/j.steroids.2025.109638_b0150) 2019; 29 Hrabálek (10.1016/j.steroids.2025.109638_b0240) 2002; 38 Bielenica (10.1016/j.steroids.2025.109638_b0080) 2017; 94 Ren (10.1016/j.steroids.2025.109638_b0175) 2018; 26 Pang (10.1016/j.steroids.2025.109638_b0280) 2023; 257 Timilsina (10.1016/j.steroids.2025.109638_b0050) 2016; 6 |
References_xml | – volume: 57 start-page: 202 year: 1992 end-page: 209 ident: b0075 article-title: Conformational mimicry. 3. Synthesis and incorporation of 1, 5-disubstituted tetrazole dipeptide analogs into peptides with preservation of chiral integrity: bradykinin publication-title: J. Org. Chem. – volume: 22 start-page: 11739 year: 2021 ident: b0020 article-title: Natural products-based drug design against SARS-CoV-2 Mpro 3CLpro publication-title: Int. J. Mol. Sci. – volume: 257 year: 2023 ident: b0280 article-title: The research progress of SARS-CoV-2 main protease inhibitors from 2020 to 2022 publication-title: Eur. J. Med. Chem. – volume: 28 start-page: 1 year: 2022 end-page: 12 ident: b0305 article-title: Reactivity and binding mode of disulfiram, its metabolites, and derivatives in SARS-CoV-2 PLpro: insights from computational chemistry studies publication-title: J. Mol. Model – volume: 6 start-page: 4108 year: 2008 end-page: 4119 ident: b0160 article-title: Effects of C-17 heterocyclic substituents on the anticancer activity of 2-ethylestra-1, 3, 5 (10)-triene-3-O-sulfamates: synthesis, in vitro evaluation and computational modelling publication-title: Org. Biomol. Chem. – volume: 87 start-page: 731 year: 2017 end-page: 738 ident: b0255 article-title: Mechanism of the zinc-catalyzed addition of azide ion to unsaturated compounds : Synthesis of 5-substituted 1 H -tetrazoles from nitriles and of 1-substituted 1 H -tetrazole-5-thiols from isothiocyanates publication-title: Russ. J. Gen. Chem. – volume: 17 start-page: 4291 year: 2021 end-page: 4300 ident: b0200 article-title: OPLS4: Improving force field accuracy on challenging regimes of chemical space publication-title: J. Chem. Theory Comput. – volume: 9 start-page: 1014 year: 2009 end-page: 1023 ident: b0090 article-title: Sulfanyltriazole/tetrazoles: a promising class of HIV-1 NNRTIs publication-title: Mini Rev. Med. Chem. – volume: 28 start-page: 235 year: 2000 end-page: 242 ident: b0205 article-title: The protein data bank publication-title: Nucleic Acids Res. – volume: 22 start-page: 5190 year: 2012 end-page: 5194 ident: b0140 article-title: Synthesis of betulinic acid derivatives as entry inhibitors against HIV-1 and bevirimat-resistant HIV-1 variants publication-title: Bioorg. Med. Chem. Lett. – volume: 32 start-page: 498 year: 2022 end-page: 500 ident: b0210 article-title: The P132H mutation in the main protease of Omicron SARS-CoV-2 decreases thermal stability without compromising catalysis or small-molecule drug inhibition publication-title: Cell Res. – volume: 15 year: 2022 ident: b0300 article-title: Discovery of triple inhibitors of both SARS-CoV-2 proteases and human cathepsin L publication-title: Pharmaceuticals – volume: 1250 year: 2022 ident: b0135 article-title: Synthesis and cytotoxic activity of 1,2,3-triazoles derived from 2,3-seco-dihydrobetulin via a click chemistry approach publication-title: J. Mol. Struct. – volume: 64 start-page: 712 year: 1987 end-page: 713 ident: b0145 article-title: Azatriterpenes. 7. Synthesis of 2-eno-[2, 3-g] tetrazolo [1, 5-a] pyrimidines of pentacyclic triterpenes publication-title: J. Indian Chem. Soc. – volume: 24 start-page: 779 year: 2016 end-page: 788 ident: b0110 article-title: Synthesis and biological evaluation of 3-tetrazolo steroidal analogs: Novel class of 5α-reductase inhibitors publication-title: Bioorg. Med. Chem. – volume: 38 start-page: 183 year: 2002 end-page: 189 ident: b0240 article-title: Synthesis of unsymmetrical sulfides derived from tetrazole-5-thiols publication-title: Chem. Heterocycl. Compd. – volume: 7 year: 2022 ident: b0070 article-title: Advances in Tetrazole Synthesis – An Overview publication-title: ChemistrySelect – start-page: 523 year: 2023 end-page: 541 ident: b0180 article-title: Synthesis of ursane-derived isothiocyanates and study of their reactions with series of amines and ammonia publication-title: J. Sulfur Chem. – volume: 26 start-page: 4452 year: 2018 end-page: 4460 ident: b0175 article-title: Cytotoxic and NF-κB and mitochondrial transmembrane potential inhibitory pentacyclic triterpenoids from Syzygium corticosum and their semi-synthetic derivatives publication-title: Bioorg. Med. Chem. – volume: 7 year: 2012 ident: b0220 article-title: An efficient computational method for calculating ligand binding affinities publication-title: PLoS One – volume: 98 start-page: 44 year: 2013 end-page: 53 ident: b0040 article-title: Oleanolic acid and ursolic acid: Novel hepatitis C virus antivirals that inhibit NS5B activity publication-title: Antiviral Res. – year: 2021 ident: b0190 article-title: Design and evaluation of bispidine-based SARS-CoV-2 main protease inhibitors, ACS Med publication-title: Chem. Lett. – volume: 112 year: 2021 ident: b0295 article-title: Ebsulfur and Ebselen as highly potent scaffolds for the development of potential SARS-CoV-2 antivirals publication-title: Bioorg. Chem. – start-page: 388 year: 2021 end-page: 403 ident: b0055 article-title: Recent developments in the synthesis of tetrazoles and their pharmacological relevance publication-title: Curr. Org. Chem. – volume: 21 start-page: 442 year: 2021 end-page: 460 ident: b0010 article-title: An updated review on SARS-CoV-2 main proteinase (MPro): protein structure and small-molecule inhibitors publication-title: Curr. Top. Med. Chem. – volume: 94 start-page: 804 year: 2017 end-page: 812 ident: b0080 article-title: 1H-Tetrazol-5-amine and 1, 3-thiazolidin-4-one derivatives containing 3-(trifluoromethyl) phenyl scaffold: Synthesis, cytotoxic and anti-HIV studies publication-title: Biomed. Pharmacother. – volume: 54 start-page: 1932 year: 2014 end-page: 1940 ident: b0215 article-title: Docking covalent inhibitors: A parameter free approach to pose prediction and scoring publication-title: J. Chem. Inf. Model. – volume: 37 start-page: 101 year: 1959 end-page: 109 ident: b0245 article-title: Isomeric 5-(substituted) aminothiatriazole and 1-substituted-tetrazolinethiones publication-title: Can. J. Chem. – volume: 6 start-page: 27403 year: 2016 ident: b0050 article-title: Identification of potent maturation inhibitors against HIV-1 clade C publication-title: Sci. Rep. – volume: 74 start-page: 1061 year: 2009 end-page: 1068 ident: b0235 article-title: Convenient one-pot synthesis of 5-(substituted amino)-1, 2, 3, 4-thiatriazoles publication-title: Collect. Czechoslov. Chem. Commun. – volume: 13 start-page: 609 year: 2021 ident: b0045 article-title: Glycyrrhizin effectively inhibits SARS-CoV-2 replication by inhibiting the viral main protease publication-title: Viruses – volume: 32 start-page: 1303 year: 2015 end-page: 1330 ident: b0120 article-title: Pentacyclic triterpenoids with nitrogen- and sulfur-containing heterocycles: Synthesis and medicinal significance publication-title: Nat. Prod. Rep. – volume: 57 start-page: 920 year: 2021 end-page: 928 ident: b0130 article-title: Synthesis, cytotoxicity, and α-glucosidase inhibitory activity of triterpenic and sitosterol tetrazole derivatives publication-title: Chem. Heterocycl. Compd. – volume: 25 start-page: 636 year: 2018 end-page: 658 ident: b0125 article-title: Click reactions in chemistry of triterpenes - advances towards development of potential therapeutics publication-title: Curr. Med. Chem. – volume: 1099 start-page: 588 year: 2015 end-page: 600 ident: b0100 article-title: DFT, Hirshfeld surfaces, spectral and in vivo cytotoxic studies of 7a-Aza-B-homostigmast-5-eno [7a, 7-d] tetrazole publication-title: J. Mol. Struct. – volume: 374 start-page: 1586 year: 2021 end-page: 1593 ident: b0290 article-title: An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19 publication-title: Science – volume: 25 start-page: 4604 year: 2020 ident: b0025 article-title: Protease inhibitory effect of natural polyphenolic compounds on SARS-CoV-2: an in silico study publication-title: Molecules – volume: 25 start-page: 2267 year: 2016 end-page: 2279 ident: b0185 article-title: Synthesis and evaluation as potential antitumor agents of novel ursolic acid derivatives publication-title: Med. Chem. Res. – volume: 153 year: 2020 ident: b0270 article-title: Synthesis of cytotoxic urs-12-ene-and 28-norurs-12-ene-type conjugates with amino-and mercapto-1, 3, 4-oxadiazoles and mercapto-1, 2, 4-triazoles publication-title: Steroids – volume: 33 start-page: 55 year: 2012 end-page: 59 ident: b0250 article-title: A facile one-pot synthesis of 1-substituted tetrazole-5-thiones and 1-substituted 5-alkyl(aryl)sulfanyltetrazoles from organic isothiocyanates publication-title: Bull. Korean Chem. Soc. – volume: 20 start-page: 145 year: 1976 end-page: 174 ident: b0265 article-title: 1, 2, 3, 4-Thiatriazoles publication-title: Adv. Heterocycl. Chem. – volume: 278 year: 2024 ident: b0015 article-title: How many organic small molecules might be used to treat COVID-19? From natural products to synthetic agents publication-title: Eur. J. Med. Chem. – volume: 60 start-page: 377 year: 2024 end-page: 389 ident: b0275 article-title: Synthesis of ursane-derived regioisomeric 2-amino-1, 3, 4-oxadiazoles and 3-thioxo-1, 2, 4-triazoles publication-title: Chem. Heterocycl. Compd. – volume: 12 start-page: 1706 year: 2022 ident: b0030 article-title: Glycyrrhizin inhibits SARS-CoV-2 entry into cells by targeting ACE2 publication-title: Life – volume: 17 start-page: 1856 year: 2017 end-page: 1868 ident: b0095 article-title: Tetrazole derivatives as promising anticancer agents, Anti-Cancer Agents Med publication-title: Chem. (formerly Curr. Med. Chem. Agents) – start-page: 1067 year: 2023 end-page: 1082 ident: b0005 article-title: Progress on SARS-CoV-2 3CLpro inhibitors: inspiration from SARS-CoV 3CLpro peptidomimetics and small-molecule anti-inflammatory compounds publication-title: Drug Des. Devel. Ther. – volume: 4 start-page: 317 year: 2013 end-page: 323 ident: b0105 article-title: Selective antitumour activity and ERα molecular docking studies of newly synthesized D-homo fused steroidal tetrazoles publication-title: Medchemcomm. – volume: 29 start-page: 1440 year: 2019 end-page: 1445 ident: b0150 article-title: Synthesis and evaluation of the HIF-1α inhibitory activities of novel ursolic acid tetrazole derivatives publication-title: Bioorg. Med. Chem. Lett. – volume: 178 start-page: 341 year: 2019 end-page: 351 ident: b0165 article-title: Tetrazole hybrids with potential anticancer activity publication-title: Eur. J. Med. Chem. – volume: 22 start-page: 441 year: 1957 end-page: 442 ident: b0225 article-title: Infrared spectrum of the so-called 5-amino 1, 2, 3, 4-thiatriazole publication-title: J. Org. Chem. – volume: 88 start-page: 644 year: 2019 end-page: 676 ident: b0060 article-title: Tetrazoles for biomedicine publication-title: Russ. Chem. Rev. – volume: 50 start-page: 2591 year: 1994 end-page: 2598 ident: b0170 article-title: Oxidative decarboxylation by hydrogen peroxide and a mercury (II) salt: A simple route to nor-derivatives of acetyloleanolic, acetylursolic and dehydroabietic acids publication-title: Tetrahedron – volume: 2 start-page: 3237 year: 2000 end-page: 3240 ident: b0260 article-title: A general synthetic method for the formation of substituted 5-aminotetrazoles from thioureas: A strategy for diversity amplification publication-title: Org. Lett. – volume: 35 start-page: 832 year: 1957 end-page: 842 ident: b0230 article-title: The reaction of nitrous acid with 4-substituted-thiosemicarbazides publication-title: Can. J. Chem. – volume: 16 start-page: 201 year: 2013 end-page: 206 ident: b0115 article-title: Synthesis, characterization, X-ray diffraction, antimicrobial and in vitro cytotoxicity studies of 7a-Aza-B-homostigmast-5-eno [7a, 7-d] tetrazole publication-title: Comptes Rendus Chim. – volume: 53 start-page: 1710 year: 2017 end-page: 1716 ident: b0085 article-title: Synthesis and anti-influenza activity of 2-cyanoethoxy and 2-(1H-tetrazol-5-yl)ethoxy derivatives of dammarane-type triterpenoids publication-title: Russ. J. Org. Chem. – volume: 3 start-page: 1265 year: 2020 end-page: 1277 ident: b0310 article-title: Ebselen, disulfiram, carmofur, PX-12, tideglusib, and shikonin are nonspecific promiscuous SARS-CoV-2 main protease inhibitors publication-title: ACS Pharmacol. Transl. Sci. – volume: 54 start-page: 601 year: 2019 end-page: 609 ident: b0035 article-title: Ursolic acid: A novel antiviral compound inhibiting rotavirus infection in vitro publication-title: Int. J. Antimicrob. Agents – volume: 10 start-page: 3379 year: 2002 end-page: 3393 ident: b0065 article-title: 5-Substituted-1H-tetrazoles as carboxylic acid isosteres: medicinal chemistry and synthetic methods publication-title: Bioorg. Med. Chem. – volume: 216 year: 2020 ident: b0155 article-title: Evaluation of ursolic acid derivatives with potential anti-Toxoplasma gondii activity publication-title: Exp. Parasitol. – volume: 65 start-page: 12500 year: 2022 end-page: 12534 ident: b0285 article-title: Targeting SARS-CoV-2 main protease for treatment of COVID-19: Covalent inhibitors structure-activity relationship insights and evolution perspectives publication-title: J. Med. Chem. – reference: Schrodinger small molecule drug discovery suite, Schrödinger, (2022) LLC, New York. – volume: 6 start-page: 4108 year: 2008 ident: 10.1016/j.steroids.2025.109638_b0160 article-title: Effects of C-17 heterocyclic substituents on the anticancer activity of 2-ethylestra-1, 3, 5 (10)-triene-3-O-sulfamates: synthesis, in vitro evaluation and computational modelling publication-title: Org. Biomol. Chem. doi: 10.1039/b810300c – volume: 17 start-page: 4291 year: 2021 ident: 10.1016/j.steroids.2025.109638_b0200 article-title: OPLS4: Improving force field accuracy on challenging regimes of chemical space publication-title: J. Chem. Theory Comput. doi: 10.1021/acs.jctc.1c00302 – volume: 20 start-page: 145 year: 1976 ident: 10.1016/j.steroids.2025.109638_b0265 article-title: 1, 2, 3, 4-Thiatriazoles publication-title: Adv. Heterocycl. Chem. doi: 10.1016/S0065-2725(08)60854-5 – volume: 22 start-page: 11739 year: 2021 ident: 10.1016/j.steroids.2025.109638_b0020 article-title: Natural products-based drug design against SARS-CoV-2 Mpro 3CLpro publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms222111739 – volume: 1250 year: 2022 ident: 10.1016/j.steroids.2025.109638_b0135 article-title: Synthesis and cytotoxic activity of 1,2,3-triazoles derived from 2,3-seco-dihydrobetulin via a click chemistry approach publication-title: J. Mol. Struct. doi: 10.1016/j.molstruc.2021.131751 – volume: 153 year: 2020 ident: 10.1016/j.steroids.2025.109638_b0270 article-title: Synthesis of cytotoxic urs-12-ene-and 28-norurs-12-ene-type conjugates with amino-and mercapto-1, 3, 4-oxadiazoles and mercapto-1, 2, 4-triazoles publication-title: Steroids doi: 10.1016/j.steroids.2019.108524 – volume: 28 start-page: 235 year: 2000 ident: 10.1016/j.steroids.2025.109638_b0205 article-title: The protein data bank publication-title: Nucleic Acids Res. doi: 10.1093/nar/28.1.235 – volume: 7 year: 2012 ident: 10.1016/j.steroids.2025.109638_b0220 article-title: An efficient computational method for calculating ligand binding affinities publication-title: PLoS One doi: 10.1371/journal.pone.0042846 – year: 2021 ident: 10.1016/j.steroids.2025.109638_b0190 article-title: Design and evaluation of bispidine-based SARS-CoV-2 main protease inhibitors, ACS Med publication-title: Chem. Lett. – volume: 374 start-page: 1586 year: 2021 ident: 10.1016/j.steroids.2025.109638_b0290 article-title: An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19 publication-title: Science doi: 10.1126/science.abl4784 – volume: 112 year: 2021 ident: 10.1016/j.steroids.2025.109638_b0295 article-title: Ebsulfur and Ebselen as highly potent scaffolds for the development of potential SARS-CoV-2 antivirals publication-title: Bioorg. Chem. doi: 10.1016/j.bioorg.2021.104889 – volume: 22 start-page: 5190 year: 2012 ident: 10.1016/j.steroids.2025.109638_b0140 article-title: Synthesis of betulinic acid derivatives as entry inhibitors against HIV-1 and bevirimat-resistant HIV-1 variants publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2012.06.080 – volume: 278 year: 2024 ident: 10.1016/j.steroids.2025.109638_b0015 article-title: How many organic small molecules might be used to treat COVID-19? From natural products to synthetic agents publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2024.116788 – start-page: 523 year: 2023 ident: 10.1016/j.steroids.2025.109638_b0180 article-title: Synthesis of ursane-derived isothiocyanates and study of their reactions with series of amines and ammonia publication-title: J. Sulfur Chem. doi: 10.1080/17415993.2023.2193669 – volume: 25 start-page: 2267 year: 2016 ident: 10.1016/j.steroids.2025.109638_b0185 article-title: Synthesis and evaluation as potential antitumor agents of novel ursolic acid derivatives publication-title: Med. Chem. Res. doi: 10.1007/s00044-016-1680-1 – volume: 38 start-page: 183 year: 2002 ident: 10.1016/j.steroids.2025.109638_b0240 article-title: Synthesis of unsymmetrical sulfides derived from tetrazole-5-thiols publication-title: Chem. Heterocycl. Compd. doi: 10.1023/A:1015387108748 – volume: 13 start-page: 609 year: 2021 ident: 10.1016/j.steroids.2025.109638_b0045 article-title: Glycyrrhizin effectively inhibits SARS-CoV-2 replication by inhibiting the viral main protease publication-title: Viruses doi: 10.3390/v13040609 – volume: 178 start-page: 341 year: 2019 ident: 10.1016/j.steroids.2025.109638_b0165 article-title: Tetrazole hybrids with potential anticancer activity publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2019.05.071 – volume: 15 year: 2022 ident: 10.1016/j.steroids.2025.109638_b0300 article-title: Discovery of triple inhibitors of both SARS-CoV-2 proteases and human cathepsin L publication-title: Pharmaceuticals doi: 10.3390/ph15060744 – volume: 3 start-page: 1265 year: 2020 ident: 10.1016/j.steroids.2025.109638_b0310 article-title: Ebselen, disulfiram, carmofur, PX-12, tideglusib, and shikonin are nonspecific promiscuous SARS-CoV-2 main protease inhibitors publication-title: ACS Pharmacol. Transl. Sci. doi: 10.1021/acsptsci.0c00130 – ident: 10.1016/j.steroids.2025.109638_b0195 – volume: 9 start-page: 1014 year: 2009 ident: 10.1016/j.steroids.2025.109638_b0090 article-title: Sulfanyltriazole/tetrazoles: a promising class of HIV-1 NNRTIs publication-title: Mini Rev. Med. Chem. doi: 10.2174/138955709788681618 – start-page: 388 year: 2021 ident: 10.1016/j.steroids.2025.109638_b0055 article-title: Recent developments in the synthesis of tetrazoles and their pharmacological relevance publication-title: Curr. Org. Chem. doi: 10.2174/18755348MTEyoMzEFz – volume: 74 start-page: 1061 year: 2009 ident: 10.1016/j.steroids.2025.109638_b0235 article-title: Convenient one-pot synthesis of 5-(substituted amino)-1, 2, 3, 4-thiatriazoles publication-title: Collect. Czechoslov. Chem. Commun. doi: 10.1135/cccc2009015 – volume: 57 start-page: 920 year: 2021 ident: 10.1016/j.steroids.2025.109638_b0130 article-title: Synthesis, cytotoxicity, and α-glucosidase inhibitory activity of triterpenic and sitosterol tetrazole derivatives publication-title: Chem. Heterocycl. Compd. doi: 10.1007/s10593-021-03001-6 – volume: 53 start-page: 1710 year: 2017 ident: 10.1016/j.steroids.2025.109638_b0085 article-title: Synthesis and anti-influenza activity of 2-cyanoethoxy and 2-(1H-tetrazol-5-yl)ethoxy derivatives of dammarane-type triterpenoids publication-title: Russ. J. Org. Chem. doi: 10.1134/S1070428017110185 – volume: 25 start-page: 636 year: 2018 ident: 10.1016/j.steroids.2025.109638_b0125 article-title: Click reactions in chemistry of triterpenes - advances towards development of potential therapeutics publication-title: Curr. Med. Chem. doi: 10.2174/0929867324666171009122612 – volume: 54 start-page: 601 year: 2019 ident: 10.1016/j.steroids.2025.109638_b0035 article-title: Ursolic acid: A novel antiviral compound inhibiting rotavirus infection in vitro publication-title: Int. J. Antimicrob. Agents doi: 10.1016/j.ijantimicag.2019.07.015 – volume: 22 start-page: 441 year: 1957 ident: 10.1016/j.steroids.2025.109638_b0225 article-title: Infrared spectrum of the so-called 5-amino 1, 2, 3, 4-thiatriazole publication-title: J. Org. Chem. doi: 10.1021/jo01355a601 – volume: 16 start-page: 201 year: 2013 ident: 10.1016/j.steroids.2025.109638_b0115 article-title: Synthesis, characterization, X-ray diffraction, antimicrobial and in vitro cytotoxicity studies of 7a-Aza-B-homostigmast-5-eno [7a, 7-d] tetrazole publication-title: Comptes Rendus Chim. doi: 10.1016/j.crci.2012.12.018 – volume: 64 start-page: 712 year: 1987 ident: 10.1016/j.steroids.2025.109638_b0145 article-title: Azatriterpenes. 7. Synthesis of 2-eno-[2, 3-g] tetrazolo [1, 5-a] pyrimidines of pentacyclic triterpenes publication-title: J. Indian Chem. Soc. – volume: 35 start-page: 832 year: 1957 ident: 10.1016/j.steroids.2025.109638_b0230 article-title: The reaction of nitrous acid with 4-substituted-thiosemicarbazides publication-title: Can. J. Chem. doi: 10.1139/v57-116 – volume: 65 start-page: 12500 year: 2022 ident: 10.1016/j.steroids.2025.109638_b0285 article-title: Targeting SARS-CoV-2 main protease for treatment of COVID-19: Covalent inhibitors structure-activity relationship insights and evolution perspectives publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.2c01005 – volume: 12 start-page: 1706 year: 2022 ident: 10.1016/j.steroids.2025.109638_b0030 article-title: Glycyrrhizin inhibits SARS-CoV-2 entry into cells by targeting ACE2 publication-title: Life doi: 10.3390/life12111706 – volume: 87 start-page: 731 year: 2017 ident: 10.1016/j.steroids.2025.109638_b0255 article-title: Mechanism of the zinc-catalyzed addition of azide ion to unsaturated compounds : Synthesis of 5-substituted 1 H -tetrazoles from nitriles and of 1-substituted 1 H -tetrazole-5-thiols from isothiocyanates publication-title: Russ. J. Gen. Chem. doi: 10.1134/S1070363217040119 – start-page: 1067 year: 2023 ident: 10.1016/j.steroids.2025.109638_b0005 article-title: Progress on SARS-CoV-2 3CLpro inhibitors: inspiration from SARS-CoV 3CLpro peptidomimetics and small-molecule anti-inflammatory compounds publication-title: Drug Des. Devel. Ther. – volume: 257 year: 2023 ident: 10.1016/j.steroids.2025.109638_b0280 article-title: The research progress of SARS-CoV-2 main protease inhibitors from 2020 to 2022 publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2023.115491 – volume: 57 start-page: 202 year: 1992 ident: 10.1016/j.steroids.2025.109638_b0075 article-title: Conformational mimicry. 3. Synthesis and incorporation of 1, 5-disubstituted tetrazole dipeptide analogs into peptides with preservation of chiral integrity: bradykinin publication-title: J. Org. Chem. doi: 10.1021/jo00027a038 – volume: 26 start-page: 4452 year: 2018 ident: 10.1016/j.steroids.2025.109638_b0175 article-title: Cytotoxic and NF-κB and mitochondrial transmembrane potential inhibitory pentacyclic triterpenoids from Syzygium corticosum and their semi-synthetic derivatives publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2018.07.025 – volume: 17 start-page: 1856 year: 2017 ident: 10.1016/j.steroids.2025.109638_b0095 article-title: Tetrazole derivatives as promising anticancer agents, Anti-Cancer Agents Med publication-title: Chem. (formerly Curr. Med. Chem. Agents) – volume: 2 start-page: 3237 year: 2000 ident: 10.1016/j.steroids.2025.109638_b0260 article-title: A general synthetic method for the formation of substituted 5-aminotetrazoles from thioureas: A strategy for diversity amplification publication-title: Org. Lett. doi: 10.1021/ol006465b – volume: 10 start-page: 3379 year: 2002 ident: 10.1016/j.steroids.2025.109638_b0065 article-title: 5-Substituted-1H-tetrazoles as carboxylic acid isosteres: medicinal chemistry and synthetic methods publication-title: Bioorg. Med. Chem. doi: 10.1016/S0968-0896(02)00239-0 – volume: 7 year: 2022 ident: 10.1016/j.steroids.2025.109638_b0070 article-title: Advances in Tetrazole Synthesis – An Overview publication-title: ChemistrySelect doi: 10.1002/slct.202200706 – volume: 24 start-page: 779 year: 2016 ident: 10.1016/j.steroids.2025.109638_b0110 article-title: Synthesis and biological evaluation of 3-tetrazolo steroidal analogs: Novel class of 5α-reductase inhibitors publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2015.12.048 – volume: 98 start-page: 44 year: 2013 ident: 10.1016/j.steroids.2025.109638_b0040 article-title: Oleanolic acid and ursolic acid: Novel hepatitis C virus antivirals that inhibit NS5B activity publication-title: Antiviral Res. doi: 10.1016/j.antiviral.2013.02.003 – volume: 33 start-page: 55 year: 2012 ident: 10.1016/j.steroids.2025.109638_b0250 article-title: A facile one-pot synthesis of 1-substituted tetrazole-5-thiones and 1-substituted 5-alkyl(aryl)sulfanyltetrazoles from organic isothiocyanates publication-title: Bull. Korean Chem. Soc. doi: 10.5012/bkcs.2012.33.1.55 – volume: 29 start-page: 1440 year: 2019 ident: 10.1016/j.steroids.2025.109638_b0150 article-title: Synthesis and evaluation of the HIF-1α inhibitory activities of novel ursolic acid tetrazole derivatives publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2019.04.028 – volume: 88 start-page: 644 year: 2019 ident: 10.1016/j.steroids.2025.109638_b0060 article-title: Tetrazoles for biomedicine publication-title: Russ. Chem. Rev. doi: 10.1070/RCR4864 – volume: 216 year: 2020 ident: 10.1016/j.steroids.2025.109638_b0155 article-title: Evaluation of ursolic acid derivatives with potential anti-Toxoplasma gondii activity publication-title: Exp. Parasitol. doi: 10.1016/j.exppara.2020.107935 – volume: 60 start-page: 377 year: 2024 ident: 10.1016/j.steroids.2025.109638_b0275 article-title: Synthesis of ursane-derived regioisomeric 2-amino-1, 3, 4-oxadiazoles and 3-thioxo-1, 2, 4-triazoles publication-title: Chem. Heterocycl. Compd. doi: 10.1007/s10593-024-03350-y – volume: 32 start-page: 498 year: 2022 ident: 10.1016/j.steroids.2025.109638_b0210 article-title: The P132H mutation in the main protease of Omicron SARS-CoV-2 decreases thermal stability without compromising catalysis or small-molecule drug inhibition publication-title: Cell Res. doi: 10.1038/s41422-022-00640-y – volume: 28 start-page: 1 year: 2022 ident: 10.1016/j.steroids.2025.109638_b0305 article-title: Reactivity and binding mode of disulfiram, its metabolites, and derivatives in SARS-CoV-2 PLpro: insights from computational chemistry studies publication-title: J. Mol. Model doi: 10.1007/s00894-022-05341-2 – volume: 37 start-page: 101 year: 1959 ident: 10.1016/j.steroids.2025.109638_b0245 article-title: Isomeric 5-(substituted) aminothiatriazole and 1-substituted-tetrazolinethiones publication-title: Can. J. Chem. doi: 10.1139/v59-015 – volume: 4 start-page: 317 year: 2013 ident: 10.1016/j.steroids.2025.109638_b0105 article-title: Selective antitumour activity and ERα molecular docking studies of newly synthesized D-homo fused steroidal tetrazoles publication-title: Medchemcomm. doi: 10.1039/C2MD20327H – volume: 21 start-page: 442 year: 2021 ident: 10.1016/j.steroids.2025.109638_b0010 article-title: An updated review on SARS-CoV-2 main proteinase (MPro): protein structure and small-molecule inhibitors publication-title: Curr. Top. Med. Chem. doi: 10.2174/1568026620666201207095117 – volume: 32 start-page: 1303 year: 2015 ident: 10.1016/j.steroids.2025.109638_b0120 article-title: Pentacyclic triterpenoids with nitrogen- and sulfur-containing heterocycles: Synthesis and medicinal significance publication-title: Nat. Prod. Rep. doi: 10.1039/C5NP00015G – volume: 50 start-page: 2591 year: 1994 ident: 10.1016/j.steroids.2025.109638_b0170 article-title: Oxidative decarboxylation by hydrogen peroxide and a mercury (II) salt: A simple route to nor-derivatives of acetyloleanolic, acetylursolic and dehydroabietic acids publication-title: Tetrahedron doi: 10.1016/S0040-4020(01)86975-1 – volume: 94 start-page: 804 year: 2017 ident: 10.1016/j.steroids.2025.109638_b0080 article-title: 1H-Tetrazol-5-amine and 1, 3-thiazolidin-4-one derivatives containing 3-(trifluoromethyl) phenyl scaffold: Synthesis, cytotoxic and anti-HIV studies publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2017.07.152 – volume: 6 start-page: 27403 year: 2016 ident: 10.1016/j.steroids.2025.109638_b0050 article-title: Identification of potent maturation inhibitors against HIV-1 clade C publication-title: Sci. Rep. doi: 10.1038/srep27403 – volume: 54 start-page: 1932 year: 2014 ident: 10.1016/j.steroids.2025.109638_b0215 article-title: Docking covalent inhibitors: A parameter free approach to pose prediction and scoring publication-title: J. Chem. Inf. Model. doi: 10.1021/ci500118s – volume: 1099 start-page: 588 year: 2015 ident: 10.1016/j.steroids.2025.109638_b0100 article-title: DFT, Hirshfeld surfaces, spectral and in vivo cytotoxic studies of 7a-Aza-B-homostigmast-5-eno [7a, 7-d] tetrazole publication-title: J. Mol. Struct. doi: 10.1016/j.molstruc.2015.07.017 – volume: 25 start-page: 4604 year: 2020 ident: 10.1016/j.steroids.2025.109638_b0025 article-title: Protease inhibitory effect of natural polyphenolic compounds on SARS-CoV-2: an in silico study publication-title: Molecules doi: 10.3390/molecules25204604 |
SSID | ssj0006392 |
Score | 2.4416838 |
Snippet | •New ursane hybrids with tetrazole and 5-aminothiatriazoles were synthesized.•New compounds were tested in vitro for SARS-CoV-2 3CLpro inhibition.•Hybrids with... A series of new heterocyclic ursane and 28-norursane hybrids - derivatives of 5-amino-1,2,3,4-thiatriazole, 1-tetrazole-5-thione, and 1-tetrazole-5-amines were... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 109638 |
SubjectTerms | Amines - chemistry Amines - pharmacology Antiviral Agents - chemical synthesis Antiviral Agents - chemistry Antiviral Agents - pharmacology Coronavirus 3C Proteases - antagonists & inhibitors Coronavirus 3C Proteases - chemistry Coronavirus 3C Proteases - metabolism Covalent bonding COVID-19 Drug Treatment Humans Molecular docking Molecular Docking Simulation Protease Inhibitors - chemical synthesis Protease Inhibitors - chemistry Protease Inhibitors - pharmacology SARS-CoV-2 - drug effects SARS-CoV-2 - enzymology SARS-CoV-2 protease Tetrazole Tetrazoles - chemistry Tetrazoles - pharmacology Thione Thiones - chemistry Thiones - pharmacology Triterpenes - chemistry Triterpenes - pharmacology Ursane hybrid |
Title | Ursane hybrids with 5-amino-1,2,3,4-thiatriazole, 1-tetrazole-5-thione, and 1-tetrazole-5-amines and study of their inhibition of main SARS-CoV-2 protease |
URI | https://dx.doi.org/10.1016/j.steroids.2025.109638 https://www.ncbi.nlm.nih.gov/pubmed/40409429 https://www.proquest.com/docview/3207202705 |
Volume | 220 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELaqcoALgpZHeVRGQpzW3cSxE_u4WlEtIHqgLNpb5NiOmqrrVLvpoRz6Q_prmXESXgJx4Bg7j1G-0Tzsmc-EvLaaW_ACKXPaOSaqXDAllGTKJrXMNWhJgt3IH0_yxVK8X8nVDpmPvTBYVjnY_t6mR2s9jEyHvzm9bBrs8c00WNcVR07_QmPeLkSBWn5086PMAzxwzxieIe2_Wv3UJXx-hFwEbeOQtptLZFbKsU_lzw7qbwFodETHD8j9IYKks17Ih2THhz2yPwuQPa-v6RsaazrjYvkeuTsfz3PbJ7fLzdYET8-usUlrS3EFlkpm1k1oWTrhk2wiWBcrnxvztb3wE5qyznebeMEkzrUBRk1wv83gO_w2TkS6WtrWNO5A0CacNVWsCsOxtWkCPZ19OmXz9gvjNJJEgBt9RJbHbz_PF2w4mYFZiDc65qRRdeUL7bM0E1YZb41Sgnulqix3gC_cUCW1kMoWuce6LAdxixaF15BB2uwx2Q0g8lNCda3z1EhZadyz9Rp5k60SRjvutErlAZmOcJSXPQFHOVamnZcjgCUCWPYAHhA9olb-okoleIl_PvtqhLkEeHDzBJBpr7ZlxpMCF4oSkOhJj_93eUSCWTLXz_7jy8_JPbzqawtfkN1uc-VfQrzTVYdRoQ_Jndm7D4uTb2UD_do |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3LbtQwFLVKWZQNghZoeRoJWI07iWMn9oLFaKCa0seCdtDsghM7aiomqWZSoWHBh_Ab_CD3OgkvgVigLmPnceXj3OvHuceEPMs1zyEKhMxqa5nIYsGUUJKpPChkrKGXBJiNfHQcT6bizUzO1sjXPhcGaZWd7299uvfWXcmwa83hRVlijm-kwbvOOGr6JzromJUHbvUR5m3Ll_uvAOTnnO-9Ph1PWHe0AMshYDbMSqOKzCXaRWEkcmVcbpQS3CmVRbEFA-GGLCiEVHkSOyQWWQi8WiROwxQoj-C918h1Ae4Cj03Y_fyDVwIhv5Uoj_CcATX7KS35fBfFD-rSok44lyjlFGNizJ8j4t9GvD7y7d0iN7shKx21rXKbrLlqk2yNKpiuz1f0BfUkUr86v0k2xv0Bclvky3SxNJWjZyvMCltSXPKlkpl5WdUsHPBBNBCs8VTr0nyqP7gBDVnjmoW_YBLr6gpKTWV_q8F3uKWv8Pq4tC6o3_KgZXVWZp6GhmVzU1b0ZPT2hI3rd4xTr0oBcfsOmV4JXnfJegUmbxOqCx2HRspM4yax0yjUnCthtOVWq1DukGEPR3rRKn6kPRXuPO0BTBHAtAVwh-getfSXvptCWPrns097mFOAB3drAJn6cplGPEhwZSoAi-61-H-3RwQ4Lef6_n98-QnZmJweHaaH-8cHD8gNrGmJjQ_JerO4dI9gsNVkj33npuT9Vf9N3wCzKDk_ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ursane+hybrids+with+5-amino-1%2C2%2C3%2C4-thiatriazole%2C+1-tetrazole-5-thione%2C+and+1-tetrazole-5-amines+and+study+of+their+inhibition+of+main+SARS-CoV-2+protease&rft.jtitle=Steroids&rft.au=Popov%2C+Sergey+A&rft.au=Shults%2C+Elvira+E&rft.au=Baev%2C+Dmitry+S&rft.au=Chirkova%2C+Varvara+Yu&rft.date=2025-08-01&rft.eissn=1878-5867&rft.volume=220&rft.spage=109638&rft_id=info:doi/10.1016%2Fj.steroids.2025.109638&rft_id=info%3Apmid%2F40409429&rft.externalDocID=40409429 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0039-128X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0039-128X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0039-128X&client=summon |